|
ZNF519 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.835900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.496200E-03 |
| Normal-vs-Stage2 |
8.785800E-02 |
| Normal-vs-Stage3 |
2.273400E-01 |
| Normal-vs-Stage4 |
3.488200E-01 |
| Stage1-vs-Stage2 |
8.411800E-01 |
| Stage1-vs-Stage3 |
5.309400E-01 |
| Stage1-vs-Stage4 |
6.042400E-01 |
| Stage2-vs-Stage3 |
7.676800E-01 |
| Stage2-vs-Stage4 |
5.770600E-01 |
| Stage3-vs-Stage4 |
5.213400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.362800E-04 |
| Normal-vs-AfricanAmerican |
5.937700E-02 |
| Normal-vs-Asian |
9.742400E-01 |
| Caucasian-vs-AfricanAmerican |
4.579700E-02 |
| Caucasian-vs-Asian |
3.186200E-01 |
| AfricanAmerican-vs-Asian |
3.430000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.221900E-04 |
| Normal-vs-Female |
2.577000E-03 |
| Male-vs-Female |
9.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.825800E-02 |
| Normal-vs-Extreme_Weight |
2.771600E-02 |
| Normal-vs-Obese |
3.443500E-03 |
| Normal-vs-Extreme_Obese |
2.678400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.924000E-01 |
| Normal_Weight-vs-Obese |
9.077800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.172800E-01 |
| Extreme_Weight-vs-Obese |
3.505600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.751400E-01 |
| Obese-vs-Extreme_Obese |
4.367600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.081250E-01 |
| Normal-vs-Age(41-60Yrs) |
1.979940E-04 |
| Normal-vs-Age(61-80Yrs) |
4.536800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.902800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.276400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.281600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.138600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.535600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.341400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.515800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.86479999999745E-05 |
| Normal-VS-Type2 PRCC |
3.095600E-01 |
| Normal-VS-KIRP CIMP |
3.967800E-01 |
| Normal-VS-Unclassified PRCC |
5.375400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.973730E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.617000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.944800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.766300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.068960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.297300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.195960E-01 |
| Normal-vs-N1 |
6.802200E-02 |
| Normal-vs-N2 |
9.820400E-01 |
| N0-vs-N1 |
1.569760E-01 |
| N0-vs-N2 |
4.799800E-01 |
| N1-vs-N2 |
7.176200E-02 |
|
|
